Use of agonists of formyl peptide receptor 2 for treating dermatological diseases
申请人:Allergan, Inc.
公开号:US10799518B2
公开(公告)日:2020-10-13
The present invention relates to a method for treating dermal inflammation and dermal diseases by local or systemic delivery, in a subject in need of such treatment, which comprises administering a pharmaceutical composition comprising a therapeutically effective amount of at least one agonist of Formyl peptide receptor 2 (FPR2).